---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/42572983.md"
description: "$Tempus AI(TEM.US) rose by over seven percentage points, showing strong momentum. The AI medical data sector has seen a lot of catalysts recently—obtaining FDA approval for tumor detection, deepening cooperation with Bristol-Myers Squibb, and the Q2 earnings report is about to be released. $Hims & Hers Health(HIMS.US) dipped slightly, while $Direxion S&P Biotech Bull 3X(LABU.US) rose a bit. Overall sentiment in the biotech sector is leaning warm.The integration of healthcare and AI is one of the most imaginative directions this year. $Tempus AI(TEM.US) focuses multimodal data on high-value indications like oncology and neurology, and its revenue path is gradually becoming clear. This rally is solidly supported by events, not just hype."
datetime: "2026-07-10T10:24:00.000Z"
locales:
  - [en](https://longbridge.com/en/topics/42572983.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/42572983.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/42572983.md)
author: "[人间半盏茶](https://longbridge.com/en/profiles/26892850.md)"
---

# $Tempus AI(TEM.US) rose by over seven percentage p…


### Related Stocks

- [TEM.US](https://longbridge.com/en/quote/TEM.US.md)
- [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)